-
Anti-Insulin-IgG ELISACatalog #: 35-INAHU-E01
Sensitivity: 1 U/mL
Range: 3 - 300 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA
Catalog #: 80-INSHUU-E01.1
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHU-E10.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Ultrasensitive Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSHUU-E10
Sensitivity: 0.135 µIU/mL
Range: 0.15 - 20 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Bovine Insulin ELISA
Catalog #: 80-INSBO-E01
Sensitivity: 0.10 ng/mL
Range: 0.25 - 6.0 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Insulin Autoantibody ELISA (IAA ELISA)
Catalog #: 21-IAAHU-E01
Sensitivity: n/a
Range: Cut-off
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSRT-E10
Sensitivity: 0.124 ng/mL
Range: 0.15 - 5.5 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Insulin ELISA
Catalog #: 80-INSHU-E01.1
Sensitivity: 0.399 µIU/mL
Range: 3 - 200 µIU/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rodent Insulin Chemiluminescence ELISACatalog #: 80-INSMR-CH01
Sensitivity: 0.089 ng/mL
Range: 0.1 - 150 ng/mL (Requires a chemiluminescent reader)
Sample Types: Plasma, Serum, Tissue Culture
Sample Size(s): 96 Wells
Detection: Chemiluminescence -
Rodent Insulin Chemiluminescence ELISA Jumbo Pack (10 Plates)Catalog #: 80-INSMR-CH10
Sensitivity: 0.089 ng/mL
Range: 0.1 - 150 ng/mL (Requires a chemiluminescent reader)
Sample Types: Plasma, Serum, Tissue Culture
Sample Size(s): 10 x 96 Wells
Detection: Chemiluminescence -
Mouse Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSMS-E10
Sensitivity: 0.06 ng/mL
Range: 0.188 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
Mouse Ultrasensitive Insulin ELISA Jumbo Pack (10 Plates)
Catalog #: 80-INSMSU-E10
Sensitivity: 0.115 ng/mL (5 µL), 0.019 ng/mL (25 µL)
Range: 0.025 - 6.9 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Multiplex Allergy
MADx Multiplex Allergy Assays &
InstrumentationALPCO is the exclusive North American distributor for the MADx ALEX2 platform for multiplex IgE allergy detection and the FOX platform for detection of IgG-mediated food intolerance.MAX
45k for Automated Sample ProcessingThe MAX 45K is a fully aut...
EOY Academic Discount
2023 Academic Discount* for Select Diabetes ELISA Kits ALPOC is excited to offer an exclusive, limited-time discount to academic institutions performing diabetes and obesity research.
Catalog Number
Description
List Price
80-INSHU-CH01
Human Ins...
Advance your GLP-1 research with optimized assays
Advance your GLP-1 research with optimized assays
The growing interest in GLP-1 receptor agonists underscores their potential, not only in helping manage diabetes and obesity, but also in offering possible benefits for kidney and heart health.
We offer an extensive portfolio of immunoassays o...
Role of IGF-1 in the Growth Hormone/IGF Axis
The Growth Hormone/IGF axis consists of IGF-1, IGF-2 and several high and low affinity IGF Binding Proteins (IGFBP). The whole system is tightly regulated by a feedback loop involving Growth Hormone (GH) secreted by the pituitary, and GH production and secretion controlled by Growth Hormone Releasin...
Emerging Biomarker Research in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in 3 adults and 1 in 10 children1. Today, liver biopsies are the only gold standard for precise diagnosis of NAFLD2. Because of this, there are tremendous efforts on the ...
A Guide to STELLUX® Chemiluminscence ELISAs: An Infographic
Today, multiple immunoassay platforms exist, providing scientists and clinicians with the means to measure a variety of biomarkers1,2,3. However, research indicates some immunoassay platforms have limitations that can inhibit progress in the laboratory4,5,6. In an effort to provide researchers with ...
A Comparison of Colorimetric and Chemiluminescence ELISAs
Are you curious about chemiluminescence ELISAs, but not exactly sure what they are, or how to use them? Our video A Comparison of Colorimetric and Chemiluminescence ELISAs discusses how similar these two types of assays are, and how they can enhance your lab testing.
Watch our video to:
Lear...
Featured Biomarkers from A to Z
This handout briefly describes the role of several important hormones measured in research.
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
June 19, 2018
ALPCO, a leading producer of research and clinical immunoassays, announced it will showcase its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA at the American Diabetes Association’s 78th Scientific Sessions June 23-25, 2018 in Orlando, FL. This new addition to the STELLUX® Chem...
Proinsulin, Insulin and Beta Cell Dysfunction
UBC Professor Bruce Verchere, PhD discusses the significance of proinsulin and insulin as biomarkers to probe beta cell dysfunction.
https://www.youtube.com/watch?v=HM5FN3D5VxI
Bone Metabolism: The Cycle of Bone Growth and Resorption
Bone metabolism is a continual cycle of bone growth and resorption that is carefully orchestrated by the dynamic relationship between osteoclasts, osteoblasts and an array of hormonal and regulatory influences. The relative levels of these signaling molecules dictate whether healthy, balanced bo...
Understanding the Role of Energy Homeostasis in Diabetes
Introduction
The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes. The key to understanding the relationship between diabetes and the...
New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time By Up To 86%
Date: January 26, 2016
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step. The unique extraction method allows laboratories to improve their sample processing time by up to 86% by extracting one sample for up to 13...
Measuring Pancreatic Elastase to Diagnose Pancreatic Disease
Many digestive system disorders and diseases can present similar types of symptoms including bloating, diarrhea, constipation, and weight gain/loss. In an effort to rule in or rule out the presence of one disease or the absence of another, clinicians will often turn to clinically approved stool-bas...
Heart Disease Biomarkers in Diabetes Research
Introduction
Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand and combat CVD complications from diabetes, 65% of diabetics will pass away from cardiovascular issues1. Part 2 of The Common Denominator eBoo...
Stool-Based Biomarkers to Differentiate Between IBD and IBS
What are IBD and IBS?
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues affecting millions of people every day. Although there is some overlap between symptoms of IBD and IBS, differences still remain in regards to pathologies, risks...
Early Detection of Diabetic Kidney Disease with Biomarkers
Introduction
Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of diabetics suffering from DKD, current methods for measuring and tracking kidney function may not be specific enough for diabetic systems2,3.
Part III of The Common ...
The Changing Roles of Bone Remodeling Biomarkers
Introduction
Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes of mineral balance and blood cell production. Research supports that bones do more than they were originally recognized for. Previous research investigating osteo...
Customer Spotlight: Measuring Functionality of Islet Microtissues
Date: July 26, 2016
Beta cell generation has gained much traction in recent years among diabetes researchers. Investigators are not only converting adipose tissue and skin cells into beta cells, they are also starting to grow beta cells in a petri dish in vitro. Swiss company InSphero has begun m...
Class IA PI3K Inhibitor Cancer Therapies
Date: August 16, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Bruton’s tyrosine kinase (BTK) inhibitors are not the only kinase inhibitors to enter the fight against B cell cancers. Since there are numerous subtypes of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), p...
PI3K Delta Signaling in Rheumatoid Arthritis
Date: September 6, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Signaling pathways dictate the differentiation, activation, and functions of immune cells. Even the slightest problem in one cell signaling pathway can transform the immune system and turn it against the body,...
[Infographic] The Benefits of Therapeutic Drug Monitoring for IBD
The Burden of Inflammatory Bowel Disease in the US and Canada
More than 1 million people in the US and 200,000 people in Canada are currently living with inflammatory bowel disease (IBD). This number is projected to grow exponentially over the next 10 years1,2. As the prevalence of IBD increases, s...